Sept 29 (Reuters) - Microport Scientific Corp 0853.HK:
ENTERS MERGER AGREEMENT FOR CRM BUSINESS RESTRUCTURING
MICROPORT CARDIOFLOW WILL ACQUIRE CRM CAYMAN THROUGH MERGER
PRE-DEAL EQUITY VALUE OF CRM CAYMAN IS $680 MILLION
MICROPORT CARDIOFLOW TO ISSUE NEW SHARES TO CRM CAYMAN SHAREHOLDERS AT HK$1.35 PER SHARE
Further company coverage: 0853.HK
((Reuters.Briefs@thomsonreuters.com;))